Publications

Improved risk prediction calculator for sentinel node positivity in patients with melanoma: The Melanoma Institute Australia nomogram

Although National Comprehensive Cancer Network (NCCN) and ASCO/Society of Surgical Oncology (SSO) guidelines and the Memorial Sloan Kettering Cancer Center (MSKCC) online nomogram are valuable for selecting patients with primary cutaneous melanoma for sentinel node (SN) biopsy, researchers aimed at generating an improved online risk calculator using alternative clinicopathologic parameters that may allow more accurate prediction of SN positivity.

Read More

Tumor immune profiling-based neoadjuvant immunotherapy for locally advanced melanoma

Given that the frequency of “exhausted” or checkpoint-positive (PD-1+CTLA-4+) cytotoxic lymphocytes (Tex) in the tumor microenvironment is correlated with response to anti-PD-1 therapy in metastatic melanoma, researchers ascertained if pretreatment Tex cells in locally advanced melanoma anticipated response to neoadjuvant anti-PD-1 blockade.

Read More
MRV News
Melanoma News
Archive
Menu